Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

2013 ◽  
Vol 165 (4) ◽  
pp. 509-514.e7 ◽  
Author(s):  
Anjan K. Chakrabarti ◽  
Kristin Feeney ◽  
Cassandra Abueg ◽  
David A. Brown ◽  
Ewa Czyz ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document